CASTAGNA, LUCA

CASTAGNA, LUCA  

DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)  

Mostra records
Risultati 1 - 20 di 25 (tempo di esecuzione: 0.017 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Selected memory T cells infused post haploidentical hematopoietic stem cell transplantation persist and hyper-expand 2022 Puccio, SimoneDi Vito, ClaraCalvi, MichelaBasso, GianlucaCibella, JavierDe Philippis, ChiaraCapizzuto, RossanaMariotti, JacopoCastagna, LucaBramanti, StefaniaMavilio, Domenico + Article (author) -
Outcome of Allogeneic Transplantation for Mature T-cell Lymphomas: Impact of Donor Source and Disease Characteristics 2022 Castagna, LucaCorradini, Paolo + Article (author) -
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide 2022 Mariotti, JacopoMavilio, DomenicoBramanti, StefaniaCastagna, Luca + Article (author) -
Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide 2021 Di Vito, ClaraTapparo, MartaMariotti, JacopoBramanti, StefaniaCalvi, MichelaCastagna, LucaMavilio, Domenico + Article (author) -
Feasibility and efficacy of CD45RA+ depleted donor lymphocytes infusion after haploidentical transplantation with post-transplantation cyclophosphamide in patients with hematological malignancies 2021 Castagna L.Capizzuto R.Mariotti J.De Philippis C.Calvi M.Mavilio D. + Article (author) -
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 2021 Castagna L.Corradini P.Guidetti A.De Philippis C. + Article (author) -
Multicenter Phase II Study on Haploidentical Bone Marrow Transplantation Using a Reduced-Intensity Conditioning Regimen and Posttransplantation Cyclophosphamide in Patients with Poor-Prognosis Lymphomas 2021 Castagna L.Onida F.Mariotti J.De Philippis C.Corradini P. + Article (author) -
Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT 2021 Calvi M.Mariotti J.De Philippis C.Castagna L.Di Vito C.Mavilio D. + Article (author) -
Single-cell profiling reveals the dynamics of cytomegalovirusspecific T-cells in haploidentical hematopoietic stem cell transplantation 2021 Puccio, SimoneZanon, VeronicaCalvi, MichelaDi Vito, ClaraDe Philippis, ChiaraMariotti, JacopoBramanti, StefaniaCastagna, LucaMavilio, Domenico + Article (author) -
Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy 2020 Mariotti J.Evangelista A.Busca A.Sperotto A.Marano L.Mavilio D.Castagna L. + Article (author) -
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma : a retrospective study of the Lymphoma Working Party—EBMT 2020 Castagna L.Corradini P. + Article (author) -
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients 2020 Castagna L.Mariotti J.Rambaldi A.Corradini P. + Article (author) -
Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide 2019 Mariotti, JacopoTaurino, DanielaBramanti, StefaniaDe Philippis, ChiaraDi Vito, ClaraMavilio, DomenicoCarlo-Stella, CarmeloCastagna, Luca + Article (author) -
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party 2019 Castagna, LucaCorradini, Paolo + Article (author) -
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBC 2019 Castagna, LucaCorradini, Paolo + Article (author) -
CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide 2018 Mussetti, A.de Philippis, C.Carniti, C.Cieri, N.Pennisi, M.Ciceri, F.Mariotti, J.Castagna, L.Corradini, P. + Article (author) -
Brentuximab vedotin prior to allogeneic stem cell transplantation in Hodgkin lymphoma: A report from the EBMT Lymphoma Working Party 2018 Castagna, LucaMartinez, CarmenCorradini, Paolo + Article (author) -
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment? 2017 F. OnidaL. CastagnaA. MussettiR. GrecoP. CorradiniA. Rambaldi + Article (author) -
Haploidentical allogeneic hematopoietic cell transplantation for multiple myeloma using post transplant cyclophosphamide GVHD prophylaxis 2017 L. CastagnaA. MussettiF. MauraC. de PhilippisP. Corradini + Article (author) -
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation : an Italian Prospective Multicenter Survey 2017 C. CattaneoS. GuidiL. CastagnaP. CorradiniA. Rambaldi + Article (author) -